Avanos Medical, a medical technology company, agreed to acquire OrthogenRx, a company specializing in treatment of knee osteoarthritis, for $160m. "The acquisition of OrthogenRx enhances our chronic pain portfolio by providing continuum of care treatment options for patients living with knee OA. This business is a clear strategic fit for Avanos, and one that will further strengthen our relationships with healthcare providers as we seek to become their preferred partner in treating musculoskeletal pain," Joe Woody, Avanos CEO.